Precision radiation offers hope for lung cancer patients too sick for surgery
NCT ID NCT03485378
Summary
This study is testing a precise form of radiation therapy for people with early-stage lung cancer who also have a serious lung-scarring disease (ILD) and cannot have surgery. The goal is to see if this targeted radiation can help patients live longer while keeping side effects manageable. Researchers will compare survival rates in patients who receive the radiation to what would be expected if they received no treatment at all.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alberta Health Services, Cross Cancer Institude
Edmonton, Alberta, T6G 1Z2, Canada
-
CHUM Université de Montréal
Montreal, Quebec, H2X 0A9, Canada
-
Edinburgh Cancer Centre, Western General Hospital
Edinburgh, EH4 2XU, United Kingdom
-
London Regional Cancer Program of the Lawson Health Research Institute
London, Ontario, N6A 4L6, Canada
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
-
UHN Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.